NationalBharat Biotech Recalls Batch Of Typhoid Vaccines After Being Flagged Over Quality IssuesBY Outlook Web Desk
Art & EntertainmentManoj Bajpayee To Narrate 'The Vial', Documentary On India's Covid Vax SuccessBY IANS
National3 Lakh Doses Of Intranasal Covid Vaccine Sent To Hospitals: Bharat Biotech's Krishna EllaBY PTI
NationalBharat Biotech's Intranasal COVID-19 Vaccine To Cost Rs 800 For Private And Rs 325 For Govt SuppliesBY PTI
NationalNasal Vaccine Against Covid-19 To Be Available On CoWIN: All You Need To KnowBY Outlook Web Desk
NationalRoutine Immunisation Suffered Due To Covid-19, It Has To Be Put Back On Track: MandaviyaBY PTI
InternationalUSA: Florida's Top Health Official Advises Against Covid mRNA Vaccines, Cites High Risk Of Heart Side EffectsBY Outlook Web Desk
NationalBharat Biotech's Covid Nasal Vaccine Gets Nod For Emergency Use: All You Need To KnowBY Outlook Web Desk
NationalNTAGI Panel Recommends Use Of Covid-19 Vaccines Corbevax, Covaxin For Children Aged 5-12 YearsBY Outlook Web Desk
NationalBharat Biotech Must Address WHO's Covaxin Suspension To Avoid EUL Cancellation, Says MEABY Outlook Web Desk
NationalCovid Vaccine Covaxin Cleared For 6-12 Age Group By Drugs Regulator DCGI: ReportsBY Outlook Web Desk
NationalSII To Give Free Covishield Vials To Pvt Vaccination Centres To Compensate For Price DifferenceBY Outlook Web Desk
NationalCOVID Vaccine Precaution Dose: Serum Institute, Bharat Biotech Cut Prices To Rs 225BY Outlook Web Desk
NationalCovaxin Booster Enhances Antibody Response Against COVID-19 Variants Including Omicron: StudyBY Outlook Web Desk
NationalIntranasal Booster Doses Against Covid-19 Are Easy To Administer | What Are These?BY Outlook Web Desk
NationalBharat Biotech's Intranasal Booster Dose Gets DCGI's Approval For Phase-3 TrialsBY Outlook Web Desk
NationalCovid-19 Vaccine For Teenagers: DCGI Grants Emergency Authorisation To CovaxinBY Outlook Web Desk
BusinessThe Jab Of Life: Covaxin’s Success Proves Bharat Biotech Was On Right PathBY Outlook Web Desk